Searched for
PRIMARY BILIARY CIRRHOSIS
Market strategy in times of war – and post-war. 11 large-cap stocks from two sectors which fit the bill for both timesThings are escalating. Despite US President Trump’s initial promise of a short and sharp war, the conflict is widening – and shows no sign ...- Possibility and probability favour them in war and peace: 10 large-cap stocks from 2 sectors with upside potential of up to 28%Probability theory is important in the stock market. Reason: Stock prices are a function of many factors and the underlying operating matri...
- Stocks in times of war and peace: Be selective and look for critical points? 5 healthcare stocks with upside potential of up to 14%In the last one year, two sectors have seen a fair amount of foreign money pouring in. One, the financial services sector, which, among oth...
- Volatility called Trump has a medicine, but being selective is a must. 7 hospital & healthcare stocks with upside potential of up to 26%Stock-selection impacts the money you make in the market. Consider this: Suppose you bought Infosys on March 8, 2000, the day the dotcom bo...
- New study finds one blood type faces a much higher risk of deadly liver diseasePeople with blood type A may have a higher chance of autoimmune liver disease, while type B seems safer. Autoimmune liver problems happen w...
- Hospital stocks: Short-term headwinds an opportunity? 10 stocks from the healthcare sector with an upside potential of up to 35%This may not have made it to the headlines, but for the last few months a tussle has been going on between health insurance companies and h...
- Healthcare: For the defence & health of your portfolio. 8 stocks from the healthcare space with upside potential of up to 39%Given the extended correction that we have witnessed, stocks of most sectors are showing negative one-year returns at this point of time. W...
- Will short-term headwinds impact long-term potential? 6 stocks from hospital sector with upside potential of up to 30%After outperforming the market, stocks from the healthcare sector or what is more commonly called hospital sector have gone into consolidat...
- Zydus bets big on proprietary drugs to boost revenueSharvil Patel, managing director of Zydus Lifesciences said, half of the research and development (R&D) allocation is geared towards develo...
- Keeping portfolio healthy in volatile times; 7 stocks from hospital sector with upside potential of up to 28%There are some businesses whose underlying nature is such that they don't have any sudden spike in their profits. However at the same time,...
- Looking for a healthy portfolio amid volatility? 8 stocks from hospital space with upside scope of up to 27%One sector which has performed extremely well in the last two years has been hospital space. If one looks at the post listing performance o...
- World Liver Day: Warning signs won’t show until it’s too late, some conditions can be reversed with good habitsThe WHO says one in five Indians is likely to suffer from a liver disease.
- Strides Pharma gets USFDA nod for generic drugBengaluru-based Strides Pharma has 127 cumulative abbreviated new drug applications (ANDA) filings with USFDA of which 96 have been approve...
- Stock in the news: HDFC Bank, Dr Reddy’s Labs, Britannia, ACC and HDFC LifeL&T Tech, Bank of Maharashtra, Rallis India and CSB Bank are slated to announce their Q2 results on Monday.
- Zydus Cadila gets USFDA nod for generic drugsThe company has received final approval from the US Food and Drug Administration (USFDA) for the medication in 300 mg strength, Zydus Cadil...
- Strides Pharma gets USFDA nod for Ursodiol tablets, a liver disease treatment drugStrides Pharma Science gets an approval from the USFDA to market Ursodiol tablets used for treating primary biliary cirrhosis, a progressiv...
- Your body's immunity can damage your liver: Watch out for these signsAutoimmune liver disease can be transmitted genetically or is caused because of some reactions wherein the liver cells are recognised as in...
- Zydus gets USFDA nod for phase II trials of liver drugThis development underlines the group's commitment to bridging unmet healthcare needs with innovative therapies.
- More younger patients are coming with liver disease: Dr Neerav Goyal, Apollo HospitalFatty liver disease progression and alcohol induced liver damage can be improved with lifestyle modifications and abstinence respectively.
- Glenmark gets USFDA nod for Ursodial; stk upGlenmark Generics, a subsidiary of Glenmark Pharmaceuticals, has been granted final approval for Ursodial tablets by the USFDA.
Load More
